| 000 | 02956 a2200733 4500 | ||
|---|---|---|---|
| 005 | 20250517063301.0 | ||
| 264 | 0 | _c20160428 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2015.62.4304 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCasali, Paolo G | |
| 245 | 0 | 0 |
_aTime to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cDec 2015 |
||
| 300 |
_a4276-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAustralasia |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aGastrointestinal Stromal Tumors _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xtherapeutic use |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aLe Cesne, Axel | |
| 700 | 1 | _aPoveda Velasco, Andres | |
| 700 | 1 | _aKotasek, Dusan | |
| 700 | 1 | _aRutkowski, Piotr | |
| 700 | 1 | _aHohenberger, Peter | |
| 700 | 1 | _aFumagalli, Elena | |
| 700 | 1 | _aJudson, Ian R | |
| 700 | 1 | _aItaliano, Antoine | |
| 700 | 1 | _aGelderblom, Hans | |
| 700 | 1 | _aAdenis, Antoine | |
| 700 | 1 | _aHartmann, Jörg T | |
| 700 | 1 | _aDuffaud, Florence | |
| 700 | 1 | _aGoldstein, David | |
| 700 | 1 | _aBroto, Javier M | |
| 700 | 1 | _aGronchi, Alessandro | |
| 700 | 1 | _aDei Tos, Angelo P | |
| 700 | 1 | _aMarréaud, Sandrine | |
| 700 | 1 | _avan der Graaf, Winette T A | |
| 700 | 1 | _aZalcberg, John R | |
| 700 | 1 | _aLitière, Saskia | |
| 700 | 1 | _aBlay, Jean-Yves | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 33 _gno. 36 _gp. 4276-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2015.62.4304 _zAvailable from publisher's website |
| 999 |
_c25452633 _d25452633 |
||